MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.55
0.00 (0.00%)
At close: 3:56PM EST
Stock chart is not supported by your current browser
Previous Close0.55
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume19,146
Market Cap8.058M
Beta2.57
PE Ratio (TTM)21.15
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q3, 2017 By the Numbers : December 6, 2017
    Capital Cube8 days ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q3, 2017 By the Numbers : December 6, 2017

    Categories: Yahoo FinanceGet free summary analysis MusclePharm Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of MusclePharm Corp. – Natural Alternatives International, Inc., GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (NAII-US, GNC-US, MYL-US and BMY-US) that have also reported for this ... Read more (Read more...)

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017
    Capital Cube4 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017

    Categories: Yahoo FinanceGet free summary analysis MusclePharm Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of MusclePharm Corp. – GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (GNC-US, MYL-US and BMY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of MSLP earnings conference call or presentation 14-Aug-17 8:30pm GMT

    Q2 2017 MusclePharm Corp Earnings Call

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017
    Capital Cube7 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017

    Categories: Yahoo FinanceGet free summary analysis MusclePharm Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of MusclePharm Corp. – GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (GNC-US, MYL-US and BMY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
    Capital Cube9 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017

    Categories: Yahoo Finance Get free summary analysis MusclePharm Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of MusclePharm Corp. – Natural Alternatives International, Inc., GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (NAII-US, GNC-US, MYL-US and BMY-US) that have also reported for this ... Read more (Read more...)

  • Arnold Schwarzenegger Lost A Bundle On Musclepharm Corp (MSLP), Says Hasta La Vista
    Insider Monkey10 months ago

    Arnold Schwarzenegger Lost A Bundle On Musclepharm Corp (MSLP), Says Hasta La Vista

    Arnold Schwarzenegger is known as a shrewd investor. Unfortunately he lost more than 80% on at least some of his investments in Musclepharm Corp (MSLP) over the last 3.5 years. During the summer of 2013 Arnold Schwarzenegger -one of the greatest muscle growth champions of all time- disclosed a 7.7 stake in MSLP whose shares […]